12:00 AM
Jan 16, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

VT-464: Phase I/II started

Viamet began a Phase I/II trial to evaluate VT-464.

Viamet Pharmaceuticals Inc., Morrisville, N.C.

Read the full 60 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >